Search results
Results from the WOW.Com Content Network
In addition to existing treatment and prevention methods, a safe and effective vaccine is needed to ensure a durable end to the HIV pandemic. As the leading U.S. government institute for biomedical HIV/AIDS research, NIAID is committed to conducting research to prevent new transmissions, end HIV-related deaths and complications, and discover a ...
HIV, or human immunodeficiency virus, is the virus that causes acquired immune deficiency syndrome (AIDS). HIV attacks the immune system by entering and destroying CD4+ T cells, a type of white blood cell that is vital to fighting off infection.
While rates of mother to child transmission of HIV have fallen over the last decade, the Joint United Nations Programme on HIV/AIDS (UNAIDS) still estimates that as many as 1.8 million children under 15 years old worldwide were living with HIV in 2017.
Since women and girls are at particularly high risk for HIV/AIDS in many parts of the world, it is especially important to have an effective, desirable vaginal microbicide as an HIV prevention tool that women can control. Read more about microbicides. Prevention of Perinatal Transmission
The National Institutes of Health (NIH) HIV Reagent Program (formerly NIH AIDS Reagent Program) has been a central resource for a wide range of infectious agents and pathogens, biological materials, and chemicals for distribution to the scientific community. The HIV Reagent Program acquires, develops, authenticates and produces high quality, authenticated research materials and provides these ...
HIV/AIDS. Vaccine Development. An Empirical Approach. A Theoretical Approach. History of HIV Vaccine Research.
The Division of AIDS (DAIDS) was formed in 1986 to develop and implement the national research agenda to address the HIV/AIDS epidemic. Toward that end, the division supports a global research portfolio to advance biological knowledge of HIV/AIDS, its related co-infections, and co-morbidities.
Diseases & Conditions HIV/AIDS Treatment HIV Treatment, the Viral Reservoir, and HIV DNA Antiretroviral therapy stops HIV from replicating (making copies of itself), which benefits the health of the person living with HIV and prevents sexual transmission of the virus.
NIAID is making every effort to eliminate the use of stigmatizing terminology and advance the use of person-first, inclusive, and respectful language. This updated HIV Language Guide (May 2024) is an important step toward that end. This resource is applicable to all communications, including but not limited to grant applications, contracts, publications, presentations, abstracts, and press ...
NIAID-supported investigators are conducting a wide range of research on all areas of HIV/AIDS, including developing and testing preventive HIV vaccines, prevention strategies, and new treatments for HIV and associated coinfections, co-morbidities, and complications. Through laboratories and clinics on the NIH campus in Bethesda, MD, and a vast network of research supported at universities ...